Nephro Care India logo

Nephro Care India MD, chairman, board of directors and AGM

NSE: NEPHROCAREHealthcare Services

Last close ₹83.00down ₹2.95 (3.43%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹85.95.

52-week range of traded prices to 23 Oct 2026
₹50.05Low, 30 Mar 2026₹156.35High, 18 Nov 2025
Market cap
₹137 Cr
P/E
No recent results
P/B
No recent results
Dividend yield
Nonein the last 12 months
Volume, NSE
19,20081.3% delivered

Nephro Care India board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

    An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

    Statutory auditor

    Named in the results for the quarter to Jun 2026.

    • K.K. Chanani & AssociatesPeer-review certificate valid to Jul 2029

    A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

    Nephro Care India AGM and shareholder votes

    Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Nephro Care India share news and announcements

    Annual general meeting, 25 Sep 2026

    1,910 shareholders on the register on 18 Sep 2026; present: 1 promoter and 22 others; votes counted by Saptasikha Jhampati / Saptasikha & Co..The company's voting result (opens in a new tab)

    1. To consider and adopt the audited Standalone & Consolidated financial statement of the Company for the financial year ended March 31, 2026 and the reports of the Board of Directors and Auditors thereon;MoreLess
      Ordinary
      100.00% for0.00% against

      Against: promoters 0.00% · institutions 0.00% · other public 0.00%

      Turnout: all 59.30% · promoters 93.91% · institutions 0.00% · other public 3.74%

    2. Dr. Pritam Sengupta (DIN: 06795012) will retire by rotation and being eligible will be re-appointed as Director.
      OrdinaryPromoters have an interest in it
      99.99% for0.01% against

      Against: promoters 0.00% · institutions 0.00% · other public 0.36%

      Turnout: all 59.30% · promoters 93.91% · institutions 0.00% · other public 3.74%

    3. Dr. Sutapa Sen (DIN: 08672795) will retire by rotation and being eligible will be re-appointed as Director.
      OrdinaryPromoters have an interest in it
      100.00% for0.00% against

      Against: promoters 0.00% · institutions 0.00% · other public 0.00%

      Turnout: all 59.30% · promoters 93.91% · institutions 0.00% · other public 3.74%

    For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

    Fines

    Reported in the filing for the quarter to Sep 2026.

    • Fine or penaltyNational Stock Exchange of IndiaSince 17 Aug 2026

      non-compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)

      As per Regulation 33(3)(d) of the SEBI LODR Regulations, 2015, “The listed entity shall submit annual audited standalone financial results for the financial year, within sixty days from the end of the financial year along with the audit report and Statement on Impact of Audit Qualifications (applicable only) for audit report with modified opinion. Provided that if the listed entity has subsidiaries, it shall, while submitting annual audited standalone financial results also submit annual audited consolidated financial results along with the audit report and Statement on Impact of Audit Qualifications (applicable only) for audit report with modified opinion.” 2.2 Further, as per Regulation 33(5) of the SEBI LODR Regulations, 2015 “For the purpose of this regulation, any reference to “quarterly/quarter” in case of listed entity which has listed their specified securities on SME Exchange shall be respectively read as “half yearly/half year” and the requirement of submitting ‘year- to-date’ financial results shall not be applicable for a listed entity which has listed their specified securities on SME Exchange. 2.3 The Company was observed to be non-complaint with respect to the submission of the half yearly Financial Results for the period ended March 31, 2026. The compliance was achieved by the Company after the delay of 28 days on June 29, 2026.MoreLess

    In the company's own words, from its latest governance filing.

    Investor complaints and compliance

    Quarter by quarter.

    Investor complaints received and resolved, the company's own count

    • Received
    • Resolved

    Open at the quarter's end

    None open at any quarter's end.
    The filing has a part on fines and penalties
    Yes
    The filing has a part on tax disputes
    No

    The company's own answers in its filing.

    How money raised was used

    The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it.